Metronidazole may display anti‐inflammatory features in periodontitis treatment: A scoping review
Molecular Oral Microbiology · 2024-08 · 39 (4) · 240-259
DOI: 10.1111/omi.12459 ↗Kurz gefasst
Scoping Review in der Zeitschrift Molecular Oral Microbiology, online erschienen am 13.04.2024. Verfasst von Lina J Suárez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Metronidazole, Periodontitis, Anti-Inflammatory Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Aim
Metronidazole (MTZ) is an antimicrobial agent used to treat anaerobic infections. It has been hypothesized that MTZ may also have anti‐inflammatory properties, but the evidence is limited and has not been previously reviewed. Thus, this scoping review aimed to answer the following question: “What is the evidence supporting anti‐inflammatory properties of metronidazole that are not mediated by its antimicrobial effects?” Methods A scoping review was conducted according to the PRISMA‐ScR statement. Five databases were searched up to January 2023 for studies evaluating the anti‐inflammatory properties of MTZ used as monotherapy for treating infectious and inflammatory diseases.
Results
A total of 719 records were identified, and 27 studies (21 in vivo and 6 in vitro) were included. The studies reported experimental evidence of MTZ anti‐inflammatory effects on (1) innate immunity (barrier permeability, leukocyte adhesion, immune cell populations), (2) acquired immunity (lymphocyte proliferation, T‐cell function, cytokine profile), and (3) wound healing/resolution of inflammation.
Conclusion
Taken together, this scoping review supported a potential anti‐inflammatory effect of MTZ in periodontitis treatment. We recommend that future clinical studies should be conducted to evaluate specific MTZ anti‐inflammatory pathways in the treatment of periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.
- Departamento de Ciencias Básicas y Medicina Oral, Universidad Nacional de Colombia, Bogotá, Colombia.
- Department of Periodontics and Dental Hygiene, School of Dentistry, University of Texas School of Dentistry at Houston, Houston, Texas, USA.
- Department of Periodontology, Estácio de Sá University, Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Basic and Translational Sciences, School of Dental Medicine University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Hospital Albert Einstein, São Paulo, São Paulo, Brazil.
ORCID-Profile: Lina J Suárez, Roger M Arce, Magda Feres
Zitieren
APA
Suárez, L. J., Arce, R. M., Gonçalves, C., Furquim, C. P., Santos, N. C. D., Retamal-Valdes, B., & Feres, M. (2024). Metronidazole may display anti‐inflammatory features in periodontitis treatment: A scoping review. Molecular Oral Microbiology, 39(4), 240-259. https://doi.org/10.1111/omi.12459
Vancouver
Suárez LJ, Arce RM, Gonçalves C, Furquim CP, Santos NCD, Retamal-Valdes B, et al. Metronidazole may display anti‐inflammatory features in periodontitis treatment: A scoping review. Molecular Oral Microbiology. 2024;39(4):240-259. doi:10.1111/omi.12459
BibTeX
@article{Surez2024,
author = {Suárez, Lina J and Arce, Roger M and Gonçalves, Cristiane and Furquim, Camila Pinheiro and Santos, Nidia Castro Dos and Retamal-Valdes, Belén and Feres, Magda},
title = {Metronidazole may display anti‐inflammatory features in periodontitis treatment: A scoping review},
journal = {Molecular Oral Microbiology},
year = {2024},
volume = {39},
number = {4},
pages = {240--259},
doi = {10.1111/omi.12459}
}
EUVIMED